Nisergoline Tablets 30 mg (Nisergoline)

Adult dose

* 5 mg, 10 mg Adults: Administer 5 ∼ 10 mg of nicergoline orally 2 ∼ 3 times daily before meals. Adjust the dose as appropriate according to symptoms. * 30 mg Adults: Administer 30 mg of nicergoline orally once daily before a meal. If the desired effect is not achieved at this dose, it may be increased to 60 mg. The dose may be reduced after symptoms improve. In patients with impaired renal function (serum creatinine >175 µmol/L) (2 mg/dL), administer a reduced dose.

This medication should not be used in certain patients. Individuals allergic to this medication or ergot alkaloids should not take it. Patients with acute heart problems or acute bleeding may be at risk if using this medication. Patients taking sympathomimetic agents or those with very slow heart rates should avoid this medication. Patients with intracranial bleeding where hemostasis has not been achieved or with orthostatic hypotension should also not use this medication. Patients with mild bradycardia or impaired renal function should use this medication with caution. During treatment, gastrointestinal symptoms such as indigestion, diarrhea, constipation, nausea, vomiting, and dry mouth may rarely occur. Liver function test values may also rise, so caution is necessary. Dizziness, changes in blood pressure, drowsiness, headache, fatigue, insomnia, and skin rashes or itching, which may indicate allergic reactions, can occur rarely. When used with antihypertensive agents, blood pressure may drop excessively, so frequent monitoring is necessary. Patients with a history of gout should be cautious as uric acid levels may be affected. Care should be taken after taking this medication regarding driving or operating machinery. This medication can interact with other drugs during its metabolic process in the liver, so patients must inform about other medications they are taking. Women who are pregnant or may become pregnant should use this medication with caution, and those who are breastfeeding should avoid it or discontinue breastfeeding if possible. Elderly patients may have decreased body function, thus requiring dosage adjustments or increased monitoring. Safety in children has not been clearly established and is not recommended. In case of overdose, blood pressure may temporarily drop, so blood pressure changes should be closely monitored and necessary actions taken. This medication should be stored out of reach of children and kept tightly closed in its original container. Storing in other containers may compromise the quality of the medication or risk misuse.

• Loss of appetite
• diarrhea
• constipation
• nausea
• vomiting
• diffuse upper abdominal pain or cramps
• thirst
• ALT elevation
• AST elevation
• dizziness

This medication should be stored in a tightly closed container to protect it from air and moisture, and the temperature should ideally be kept between 1 and 30 degrees Celsius at room temperature. This storage method will help maintain the medication's efficacy for a longer period.

Appearance

Pale yellow round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle